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Abstract
A single strain of Mycobacterium massiliense (BRA 100), a subspecies of the Mycobacterium abscessus complex, has been responsible for an
epidemic of post-surgical infections in Brazil. Outside Brazil, this is the ﬁrst report to describe a single emerging strain of M. massiliense (TPE
101) associated with extrapulmonary infections. This phenomenon may be underestimated because sophisticated molecular typing of
M. abscessus is not routinely performed. Our molecular epidemiology study was triggered by an outbreak investigation. Nine case isolates
were grown from the surgical sites of nine mostly paediatric patients receiving operations from 2010 to 2011. All available non-duplicated
isolates of M. abscessus during this period were obtained for comparison. Mycobacteria were characterized by multilocus sequence analysis
(MLSA), repetitive sequence PCR (rep-PCR) and pulsed-ﬁeld gel electrophoresis (PFGE). Of 58 isolates of M. abscessus overall, 56 were
clinical isolates. MLSA identiﬁed 36 of the isolates as M. massiliense. All case isolates were indistinguishable by PFGE and named the TPE 101
pulsotype. Of the stored strains of M. abscessus, TPE 101 strains were over-represented among the control surgical wound (7/7, 100%) and
subcutaneous tissue isolates (4/5, 80%) but rare among the respiratory isolates (1/16, 6%) and absent from external skin, ocular and
environmental samples. In conclusion, a unique strain of M. massiliense has emerged as a distinctive pathogen causing soft tissue infections in
Taiwan. Further study to identify whether this is due to an occult common source or to speciﬁc virulence factors dictating tissue tropism is
warranted.
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Introduction
Infections by rapidly growing mycobacteria (RGM) are increas-
ing in hospitals worldwide [1–3]. Outbreaks caused by RGM
have been reported following injections or minimally invasive
surgery [4–7]. In those outbreaks, members of the M. chelonae–
M. abscessus group were most often identiﬁed, with M. absces-
sus representing a complex whose members have undergone
several taxonomic revisions in recent years. Speciﬁcally,
M. massiliense and M. bolletii, ﬁrst described in 2004 and
2006, respectively [8,9], both as a separate species to
M. abscessus on the basis of rpoB gene sequencing, were later
united and reclassiﬁed in 2011 as subspecies M. abscessus
subsp. bolletii by extensive molecular characterization, including
DNA-DNA hybridization and RFLP-16S rRNA [10], and
M. abscessus as M. abscessus subsp. abscessus. Distinguishing
subspecies seems clinically important due to unique disease
manifestations and susceptibilities, yet our understanding of
M. massiliense as a distinct and emerging pathogen is still
evolving.
An epidemic of iatrogenic infections from 2004 to 2010 was
reported in seven regions of Brazil (at least 2032 notiﬁed cases
in 63 hospitals) [11]. Unusually, these infections were due to a
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single clone of M. massiliense (BRA 100), now reclassiﬁed
under M. abscessus subsp. bolletii [10]. Outside of Brazil, no
widespread emergence of such a dominant clone of M. mas-
siliense has been identiﬁed. Here we present a study on
molecular epidemiology that was triggered by an outbreak
investigation at a medical centre in Taiwan.
Materials and Methods
Background and setting
From February 2010 to February 2011, based on an initial report
by a paediatrician, a cluster of surgical wound and bloodstream
infections with Mycobacterium abscessus occurred in nine
patients, mostly children, following cardiac surgery performed
in two adjacent operating rooms of a medical centre in Taipei,
Taiwan. Over 35 000 inpatient operations are performed
annually in 48 operating theatres of this medical centre [12].
None of the patients were initially suspected to have
mycobacterial infections, and all M. abscessus isolates were
recovered from specimens subjected to routine cultures and
isolation methods for bacteria. To characterize the increasingly
signiﬁcant M. abscessus complex we used molecular identiﬁca-
tion based on three housekeeping genes, an automated
repetitive-sequence-based PCR (rep-PCR), and pulsed-ﬁeld
gel electrophoresis (PFGE) to study the nine epidemiologically
related isolates. For comparison, all stored clinical isolates of
RGM were obtained from our mycobacteriology database
during the same time period and characterized by PCR
sequencing. Two environmental RGM isolates were cultured
following extensive environmental survey (131 equipment
samples, 22 samples from surgical staff, and 20 water and eight
air samples). Demographics and clinical data were obtained by
retrospective chart review. Nosocomial infections were
deﬁned according to the CDC/NHSN criteria for infections
in the acute care settings [13].
Laboratory methods
The mycobacterial strains were stored at 80°C in GermBank
[Creative Media Products (Wugu Shiang, Taipei County,
Taiwan)]. Prior to use, the strains were subcultured onto
Middlebrook 7H11 agar (Creative Media Products, Wugu
Shiang). Isolation of non-tuberculous mycobacteria from tap
water and showers was performed as detailed previously [14].
PCR ampliﬁcation and sequencing of three housekeeping
genes
Mycobacterial DNA was extracted as described previously
[15]. PCRs using the primers listed in Table 1 were performed
to amplify fragments of the three housekeeping genes hsp65,
rpoB and secA [16]. Sequences were analysed for their similarity
with sequences in the GenBank database using the Basic Local
Alignment Tool (BLAST; http://www.ncbi.nlm.nih.gov/BLAST)
and compared with type strains of M. abscessus subspecies
abscessus (ATCC 19977) and M. massiliense (CIP 108297).
Analysis was performed using minimum spanning trees (Bio-
Numerics V.6.0; Applied Maths, Sint-Martens-Latem Belgium).
Repetitive sequence PCR ﬁngerprinting (Rep-PCR)
The DiversiLab Mycobacterium typing kit (Bacterial Barcodes,
Inc., a subsidiary of bioMerieux, Inc., Athens, GA, USA) was
used for rep-PCR typing of the mycobacterial isolates, accord-
ing to the manufacturer’s instructions. Ampliﬁed fragments of
various sizes and intensities were separated and detected by
using a microﬂuidics chip with the Agilent 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, CA, USA). Further analysis
was performed with DiversiLab software. The reports gener-
ated included dendrograms and virtual gel images.
Pulsed-ﬁeld gel electrophoresis (PFGE)
The electrokaryotypes of environmental and clinical isolates
were analysed by PFGE using restriction endonucleases (AseI
and XbaI) (New England Biolabs, Beverly, MA, USA) as
previously described [12]. The PFGE patterns were deter-
mined by using the Pearson product-moment correlation
coefﬁcient, with the software package Gel Compare II (Applied
Maths BVBA, Texas) [17]. Isolates were considered to belong
to the same pulsotypes if they exhibited similarity of 90% of
their banding patterns and to be indistinguishable, closely
related or possibly related if they exhibited zero, two to three
or four to six band differences with both enzymes, respectively
[18].
TABLE 1. Primers used for PCR and sequencing
Gene
locus Primer name and sequence
Product
length (bp) Ampliﬁcation conditions
Bases
analysed (bp) Analysed fragment Reference
hsp65 hsp65-F 5′-ACCAACGATGGTGTGTCCAT-3′ 441 94°C 5 min; 35 cycles: 94°C 30 s,
60°C 30 s, 72°C 30 s; 72°C 10 min
401 5′-CGCCAAGGAG…
GAGCTCACCG-3′
[16]
hsp65-R 5′-CTTGTCGAACCGCATACCCT-3′
rpoB rpoB-F 5′-GGCAAGGTCACCCCGAAGGG-3′ 752 94°C 5 min; 30 cycles: 94°C 30 s,
64°C 30 s, 72°C 45 s; 72°C 10 min
711 5′-TGARACCGAG…
GBCCGTACTC-3′
[16,28]
rpoB-R 5′-AGCGGCTGCTGGGTGATCATC-3′
secA1 secA1-F 5′-GACAGYGAGTGGATGGGYCGSG
TGCACCG-3′
519 94°C 5 min; 30 cycles: 94°C 30 s,
65°C 30 s, 72°C 30 s; 72°C 10 min
466 5′-CTTCCTVGGS…
RCTRTTCMMS-3′
[16]
secA1-R 5′-GCGGACGATGTARTCCTTGTCSCG-3′
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Results
In total, 67 isolates of RGM were studied (Fig. 1a). Nine case
isolates were grown from the infected surgical site or
bloodstream of patients who received at least one operation
in the hospital between 1 February 2010 and 28 February
2011. Fifty-eight isolates of all available RGM stored during the
period of study were obtained for comparison and molecular
characterization. Of these 58 control isolates, 54 were clinical
(b)
(a)
FIG. 1. (a) Study ﬂow processing 67 isolates of rapidly growing mycobacteria. (b) Phylogenetic trees derived from the individual and integrated
concatenated hsp65, rpoB and secA sequences. The trees were constructed using minimum spanning trees (BioNumerics V.6.0, Applied Maths). All
nine case isolates (red) were identiﬁed as Mycobacterium massiliense. Among the various control isolates, nine isolates were identiﬁed to be RGM
other than Mycobacterium abscessus species, namely M. chelonae (n = 3, two from respiratory specimens, type strain ATCC35752), M. fortuitum
(n = 3, two from surgical wound specimens, one from non-surgical wound specimens), Gordonia species (n = 2, both from respiratory specimens)
and M. senaqalense (n = 1, environmental isolate). Only one M. abscessus isolate (4752) had conﬂicting subspecies assignments by use of the hsp65
and rpoB, with 100% identiﬁcation as subsp. abscessus with the hsp65 gene, and 99.9% and 100% identiﬁcation as M. massiliense by rpoB and secA1,
respectively.
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isolates, two were environmental isolates, and two were
standard isolates used for quality control: M. abscessus
(ATCC19977) and M. chelonae (ATCC35752).
Multilocus sequence analysis (MLSA)
Of the 67 mycobacterial isolates, nine isolates were identiﬁed
by MLSA to be RGM other than M. abscessus species, namely
M. chelonae (n = 3), M. fortuitum (n = 3), Gordonia species
(n = 2) and M. senaqalense (n = 1) (Fig. 1a,b). These were
excluded from subsequent PFGE and strain typing by rep-PCR.
There were 58 isolates of M. abscessus sensu lato overall, of
which 56 were clinical isolates, one was an environmental
isolate and one was our standard reference strain (ATCC
19977). Out of these 56 clinical isolates, there were 21
(37.5%), 22 (35.7%) and 19 (33.9%) isolates identiﬁed as
subspecies abscessus by hsp65, rpoB and secA1 partial gene
sequencing, respectively (Table 2). The remaining 35 (62.5%),
36 (64.3%) and 37 (66.1%) isolates were identiﬁed as subspecies
bolletii by hsp65, rpoB and secA1 partial gene sequencing,
respectively. Only two M. abscessus sensu lato isolates (ID.
4752 and 4753) had conﬂicting subspecies assignments by
individual gene sequence analysis. These two isolates formed
separate clades between the two subspecies in the integrated
phylogenetic analysis.
The majority of M. abscessus sensu lato clinical isolates
(71.4%, 40/56) showed perfect agreement in not only subspe-
cies but also clade assignments. Overall using three primers,
our subspecies bolletii clinical isolates (n = 36) clustered
together into six genotypes and our subspecies abscessus
clinical isolates (n = 20) into ﬁve genotypes. All nine case
isolates were identiﬁed as M. massiliense and were indistin-
guishable by MLSA (Table 3). This ‘outbreak’ strain was
referred to as the M. massiliense 1 genotype.
Eleven of the 16 respiratory isolates were identiﬁed as
M. abscessus subsp. abscessus (hereafter for brevity M. absces-
sus) and ﬁve were identiﬁed as M. massiliense, of which only
one was of the M. massiliense 1 genotype. In contrast, all
except one of the seven non-outbreak surgical wound samples
were identiﬁed as the M. massiliense 1 genotype. The
Mycobacterium massiliense 1 genotype was over-represented
among the sterile biopsied subcutaneous tissue, lymph node
and body cavity ﬂuid cultures (Table 3).
PFGE
All nine case isolates were indistinguishable by PFGE and
termed the TPE101 pulsotype (Fig. 2). Only one (6.3%) of the
remaining 16 respiratory control specimens belonged to the
TPE 101 pulsotype. In contrast, all (100%) of the remaining
seven surgical wound controls were also of the TPE 101
pulsotype. TPE 101 pulsotypes were also randomly found
among sterile site isolates such as the blood (33.3%), lymph
node (40%), body cavity ﬂuid specimens (66.7%) and subcu-
taneous tissues (80%), but not at all among cultures from the
eye (Fig. 3).
The PFGE patterns for M. abscessus isolates were much less
conserved and prone to the previously reported problem of
smearing [19]. Only two pairs of isolates of M. abscessus
displayed an electrophoretic gel pattern of >90% similarity.
Moreover, of 22 M. abscessus isolates, ten were non-typeable
due to DNA degradation, whilst only one of 36 isolates of
M. massiliense smeared. Thus, for M. massiliense, PFGE was
100% reproducible and 97% typeable, consistent with previous
studies [20]. PFGE correlated well with MLSA genotype.
Rep-PCR
In order to further discriminate between members of the
major M. massiliense genotype 1 or TPE 101 pulsotype, we
used a commercial high-throughput rep-PCR optimized for the
typing of M. massiliense and M. abscessus [16,21]. We found
that rep-PCR had higher discriminative power than PFGE but
the comparative relatedness between clades differed.
The virtual gel images generated are shown in Fig. 4. A cut-
off of <70% similarity in rep-PCR appeared to distinguish
between the two subspecies, M. massiliense and M. abscessus,
whereas a maximal difference of 26% in rep-PCR was observed
between PFGE identiﬁed closely related strains of TPE 101,
and 80% similarity clustered all nine cases of ‘outbreak strains’
of TPE 101.
TABLE 2. Comparison of gene sequences from clinical isolates and reference strains of Mycobacterium abscessus subspecies
abscessus (ATCC 19977) and Mycobacterium massiliense (CIP 108297)
Organism
hsp65 rpoB secA
No. of isolates % Identity No. of isolates % Identity No. of isolates % Identity
M. abscessus subspecies abscessus 19
2
100
99.8
19
1
100
99.9
17
2
100
99.8
Total 21 20 19
M. massiliense 35 100 2
34
99.9
99.7
8
26
1
100
99.8
98.7
Total 35 36 37
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The only M. massiliense 1 isolated from sputum (ID.4961)
was only 75% similar by rep-PCR to the ‘outbreak strain’,
despite being closely related (two-band difference) by PFGE,
and the only M. massiliense 1 isolated from blood (ID.4966)
was only 74% similar by rep-PCR to the ‘outbreak strain’
(representing the maximal difference) yet indistinguishable by
PFGE.
One major cluster (A) was identiﬁed by rep-PCR for
M. massiliense, and two major clusters (X, Y) for M. abscessus.
Within the major cluster (A) using an arbitrary cut-off of 90%
similarity, there were two subgroups (A1, A2), with half the
cases falling into each group. There were three subgroups (X1,
X2, X3) and two subgroups (Y1, Y2) within the major clusters
of M. abscessus. As the other two more traditional molecular
typing methods were unable to distinguish and therefore sub-
classify the strains clustered by rep-PCR at 90% similarity, the
signiﬁcance of these subgroups is unknown.
Clinical characteristics
The 56 M. abscessus sensu lato clinical strains were isolated
from 54 patients. Two patients contributed two isolates each;
isolate Nos. 4742 (M. massiliense) and 4743 (M. abscessus)
were obtained from the infected ear of one patient 1 month
apart and isolate Nos. 4741 and 4745 (both M. massiliense)
were cultured from the infected local anaesthetic injection
sites of another individual 3 months apart. The median age of
TABLE 3. Molecular characterization of 58 isolates of Mycobacterium abscessus sensu lato
Isolate origin Isolate ID hsp 65 rpo B sec A1 3 primers PFGE
Case 1 4756 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Case 2 4725 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Case 3 4721 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Case 4 4718 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Case 5 4726 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Case 6 4717 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Case 7 4722 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Case 8 4973 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Case 9 4975 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Surgical wound 1 4738 M. massiliense 1 M. massiliense 3 M. massiliense 1 M. massiliense 3 TPE 101
Surgical wound 2 4741 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Surgical wound 3 4745 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Surgical wound 4 4750 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Surgical wound 5 4754 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Surgical wound 6 4759 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Surgical wound 7 4974 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Subcutaneous 1 4735 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Subcutaneous 2 4747 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Subcutaneous 3 4945 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Subcutaneous 4 4952 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Subcutaneous 5 4956 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Ascites 1 4752 M. abscessus 1 M. massiliense 4 M. massiliense 2 M. massiliense 6 M3
Ascites 2 4755 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Pleural effusion 1 4737 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Lymph node 1 4740 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Lymph node 2 4753 M. abscessus 1 M. abscessus 1 M. bolletii M. abscessus 5 A1
Lymph node 3 4946 M. abscessus 1 M. abscessus 2 M. abscessus 2 M. abscessus 4 A2
Lymph node 4 4948 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Lymph node 5 4957 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Blood 1 4947 M. massiliense 1 M. massiliense 2 M. massiliense 2 M. massiliense 2 M2
Blood 2 4953 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Blood 3 4966 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Eye 1 4739 M. abscessus 2 M. abscessus 1 M. abscessus 1 M. abscessus 2 A3
Eye 2 4751 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Eye 3 4954 M. massiliense 1 M. massiliense 2 M. massiliense 2 M. massiliense 2 M2
Eye 4 4965 M. massiliense 1 M. massiliense 1 M. massiliense 4 M. massiliense 4 M4
External skin 1 4742 M. massiliense 1 M. massiliense 2 M. massiliense 2 M. massiliense 2 M2
External skin 2 4743 M. abscessus 1 M. abscessus 1 M. abscessus 2 M. abscessus 3 A4
External skin 3 4749 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 A5
External skin 4 4950 M. massiliense 1 M. massiliense 2 M. massiliense 2 M. massiliense 2 M2
Respiratory 1 4736 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 A6
Respiratory 2 4943 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Respiratory 3 4951 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 A6
Respiratory 4 4955 M. massiliense 1 M. massiliense 2 M. massiliense 2 M. massiliense 2 M2
Respiratory 5 4958 M. massiliense 1 M. massiliense 2 M. massiliense 2 M. massiliense 2 M2
Respiratory 6 4959 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Respiratory 7 4960 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Respiratory 8 4961 M. massiliense 1 M. massiliense 1 M. massiliense 1 M. massiliense 1 TPE 101
Respiratory 9 4962 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 A6
Respiratory 10 4963 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Respiratory 11 4967 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
Respiratory 12 4968 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 A7
Respiratory 13 4969 M. massiliense 1 M. massiliense 4 M. massiliense 3 M. massiliense 4 Smear
Respiratory 14 4970 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 A8
Respiratory 15 4971 M. massiliense 1 M. massiliense 2 M. massiliense 2 M. massiliense 2 M2
Respiratory 16 4972 M. abscessus 2 M. abscessus 1 M. abscessus 1 M. abscessus 2 A3
Environment 1 4925 M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 Smear
ATCC 19977 Type M. abscessus 1 M. abscessus 1 M. abscessus 1 M. abscessus 1 -
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the patients was 46.6 years (range 1 month old to 97 years
old). Fifty-seven per cent (31 of 54) of the patients were female
and were patients on surgical wards (the remaining 23 patients
were male and admitted to medical wards). Table 4 lists the
demographics and clinical characteristics of the nine case
patients. With one exception, all were paediatric patients and
female. The majority had congenital heart disease and received
corrective surgery. Four patients died after prolonged hospi-
talization from causes unrelated to their post-surgical NTM
infections.
In our cohort, skin and soft tissue NTM infections were
most common (39%, 21/54), followed by disseminated NTM
infections (14.8%, 8/54). Of the 16 patients with positive
sputum isolates, only three had suggestive clinical and/or
radiological ﬁndings and more than two sputum isolates,
meeting the diagnostic criteria for NTM lung disease according
to the ofﬁcial ATS/IDSA statement [22]. The remaining isolates
were cultured from two patients with NTM lymphadenitis,
two with chronic otitis media complicated with mastoiditis,
four with traumatic eye infections, and lastly a patient with
cholangiocarcinoma who developed secondary peritonitis with
repeated paracenteses failing to implicate another pathogen.
Discussion
The clinical signiﬁcance of M. massiliense has increased follow-
ing the recent taxonomic reclassiﬁcation of three intimately
related RGMs: M. abscessus, M. massiliense and M. bolletii
[3,23–25]. However, the identiﬁcation of M. massiliense is
not straightforward. While some have identiﬁed M. massiliense
based on hsp65 partial sequencing alone [26], this is not the
established standard. Neither can rpoB sequencing accurately
identify M. massiliense because horizontal transfer of the rpoB
gene between these subgroups may have occurred [27].
Consequently, most studies have used the combination of rpoB
and hsp65 sequences but discordant subspecies assignments
have resulted [16]. Thus, in this study secA1 was used to
FIG. 2. Dendrogram of AseI pulsed-ﬁeld gel electrophoretic patterns. Red line and box indicates isolates with 90% similarity by PFGE. ID,
identiﬁcation number of isolate. Cases of M. massiliense infections occurring post-surgery at the Children’s Hospital are numbered chronologically
from 1 to 9. Control specimens were obtained from patients who had never received surgery at the Children’s Hospital from the following sites: SW,
surgical wound; LN, lymph node; SPU, sputum; SC, subcutaneous tissue. TPE 101 refers to the major pulsotype; other, all other pulsotypes. MLSA,
multilocus sequence analysis based on three genes identiﬁed the isolate to the subspecies level. Rep-PCR, repetitive sequence PCR ﬁngerprinting was
used to subgroup identical pulsotypes into repotypes with at least 80% similarity into A, B, C and so forth for M. massiliense (M. abscessus subspecies
bolletii) and X, Y, Z and so forth for M. abscessus (M. abscessus subspecies abscessus). Numbers after the capital letter denote strains with at least 90%
similarity by rep-PCR as in A1, A2, D1 and Y1, Y2.
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resolve incongruent designations of M. massiliense by rpoB and
hsp65. Other studies have used sodA and 16S-23S ITS
sequencing [25].
In accordance with other studies, M. bolletii (CIP 108541) is
less commonly isolated clinically than either M. abscessus or
M. massiliense strains. Only one clinical isolate matched the
M. bolletii (CIP 108541) type strain by>98.7%. This questions the
use of M. bolletii (CIP 108541) rather than M. massiliense (CIP
108297) as the type strain of M. abscessus subsp. bolletii [10].
Compounded by the difﬁculties in accurate identiﬁcation,
little is known regarding the genetic diversity of M. massiliense
[16,28]. Zelazny et al. [16] showed that by partial sequencing
by hsp65, all of their M. massiliense isolates (n = 12) clustered
into one group, while that by rpoB clustered only seven of the
above 12 into two genotypes. On the other hand, Kim et al.
found that their M. massiliense isolates (n = 65) clustered into
two or four distinct genotypes by hsp65 and rpoB sequencing,
respectively [26].
TPE 101 – M. massiliense outbreak strain pulsotype A
Other types – M. abscessus and M. massiliense strains unrelated to pulsotype A
SW – surgical wound control isolates, SC – subcutaneous tissue isolates, AS/PE – ascites/pleural effusion, LN – lymph node, BLD – blood, Env. - environment
Case SW SC AS/PE LN BLD SPU Skin Eye Env.
Other types 0 0 1 1 3 2 15 4 4 1
TPE 101 9 7 4 2 2 1 1 0 0 0
0%
20%
40%
60%
80%
100%
M
aj
or
 v
er
su
s 
ot
he
r 
pu
ls
ot
yp
e 
pe
rc
en
ta
ge
FIG. 3. The skewed distribution of isolates of the major pulsotype of M. massiliense (TPE 101) among 58 isolates of M. abscessus sensu lato by tissue
type, with a predominance among samples obtained from surgical wounds, subcutaneous tissues and serous ﬂuid from body cavities, but low
representation among sputum, skin surface, ocular and environmental samples. TPE 101, M. massiliense outbreak strain pulsotype A. Other types,
M. abscessus and M. massiliense strains unrelated to pulsotype A. SW, surgical wound control isolates; SC, subcutaneous tissue isolates; AS/PE,
ascites/pleural effusion; LN, lymph node; BLD, blood; Env., environment.
FIG. 4. Virtual gel image generated by
Rep-PCRusing theDiversilabMycobacterium
Strain Typing kit (Diversilab v3.4).
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Consistentwith and using a sample size that is intermediate to
these two studies, our M. massiliense clinical isolates (n = 36)
clustered together into one genotype by hsp65, two genotypes
by rpoB, and six genotypes by all three primers. The shorter
length of the hsp65 sequenced product may explain why all our
and Zelazny’sM. massiliense isolates clustered into one genotype
by hsp65, as comparedwith rpoB (441 vs. 752 bp). A longer hsp65
sequenced product (441 vs. 603 bp) may also have enabled the
Korean investigators to identify more than one genotype with
hsp65. We conclude that hsp65 can rapidly distinguish between
subspecies of M. abscessus but longer sequenced products
discriminates clades better within subspecies.
With PFGE, we found the recurring theme of a dominant
strain of M. massiliense (TPE 101) associated with extrapulmo-
nary infections. Like the identiﬁcation of a unique strain of
M. massiliense, named BRA100, in the Brazilian epidemic of post-
surgical infections [4,6,29], our ﬁndings may suggest an outbreak
or pseudo-outbreak on a larger scale than the scope of this
study. Alternatively, it may suggest a spread of a particularly
pathogenic or nosocomial adapted strain of RGM. A study
showing increased virulence and pathogenicity in vivo of the
BRA100 epidemic strain was recently published [30]. In this
study, animals infectedwith the Brazilian epidemic strain showed
a progressive and extensive lung infection characterized by a
delayed inﬂux of CD4+ andCD8+T cells, and increased numbers
of pulmonary CD4+ Foxp3+ regulatory T-cells compared with
those infected with the reference strain. This suggests that
altering the levels of regulatory T cells may have an impact on the
RGM’s virulence and ability to persist in the host [30].
Although Matsumoto et al. [31] have conﬁrmed that PFGE
can appropriately type M. abscessus isolates, PFGE-related
strains are not necessarily considered the same. In their study,
only two of 32 sputum isolates were highly similar (91.45%) by
PFGE to those of the epidemic strain. Similarly, we found that
only one of 16 sputum isolates was similar to the TPE 101
pulsotype. Despite the PFGE similarities, Matsumoto et al. [31]
considered the sputum isolates to represent a different strain
or a biological variant of the epidemic strain on the basis of
distinct biological properties, such as clarithromycin resistance
and susceptibility to glutaraldehyde.
Althoughwedid not study the biological characteristics of our
isolates, using rep-PCR, we were able to show that the TPE101
isolates from sputum and blood samples were maximally
different (25–26% divergence by DiversiLab) from the outbreak
TPE 101 surgical isolates. In contrast, all surgical wound and soft
tissue TPE 101 isolates, showed >80% similarity by rep-PCR to
the outbreak strain. Hence rep-PCR typingmaymore sensitively
discriminate between PFGE-related strains.
While the BRA100 strain’s high level resistance to glutar-
aldehyde and increased virulence factors have been advanced
as likely reasons for its selection and dissemination across
Brazil [30,32], given the limitation of this molecular study to a
single centre, a common source to which soft tissue is exposed
after breach of skin by mechanisms other than surgery, cannot
be excluded as the explanation for the emergence of such a
dominant strain among our clinical isolates. Neither is a
pseudo-outbreak excluded because laborious characterization
permitting the identiﬁcation of M. massiliense is usually only
undertaken under circumstances of an outbreak investigation,
leading to an inherent bias in the reporting of this entity as the
cause of such outbreaks.
Conclusion
Using MLSA, PFGE and rep-PCR, this is the ﬁrst report of a
single emerging strain of M. massiliense (TPE 101) associated
with extrapulmonary infections outside Brazil.
TABLE 4. Nine epidemiologically related cases of Mycobacterium massiliense infections
No. Sex (age)
Underlying
diseases
Date of
surgery
Operator/ OP
room Operation
OP to
SSI
(days)
Site of Mycobacterium
abscessus Outcome
1 Girl (6 months) Jejunal atresia and
ileal stenosis
2010/02/10 Surgeon A/ CH67 Exploratory laparotomy
and thoracostomy
54 Chest drain surgical wound Died 98 days later
2 Man (47 years) Transposition of
great arteries
2010/04/29 Surgeon B/
CH68
Norwood procedure 46 Sternotomy surgical wound Died 23 days later
3 Girl (16 years) Acute myocarditis 2010/05/18 Surgeon A/
CH68
ECMO with ventricular
assist device
27 Blood (ECMO) and surgical
wound
Died 91 days later
4 Girl (1 month) Ventricular septal
defect
2010/07/22 Surgeon A/
CH67
Repair ventricular septal
defect
19 Sternotomy surgical wound Discharged alive
5 Girl (11 months) Neuroblastoma 2010/9/10 Surgeon A/ CH62 Exploratory laparotomy
and thoracostomy
10 Chest drain surgical wound Discharged alive
6 Girl (7 months) Congenital heart
disease
2010/9/20 Surgeon A /CH67 PDA ligation and RVOT
patch
30 Sternotomy surgical wound Discharged alive
7 Girl (1 month) Transposition of
great arteries
2010/10/2 Surgeon B /CH67 Norwoood procedure 32 Sternotomy surgical wound Discharged alive
8 Girl (13 years) Acute myocarditis 2011/1/26 Surgeon A
/CH67
ECMO and LV drain 17 Blood culture Discharged alive
9 Girl (3 months) Endocardial cushion
defect
2011/2/11 Surgeon A /CH68 Pulmonary artery ligation 13 Blood culture Died 121 days later
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